Literature DB >> 4106334

Immunologic enhancement of rat kidney grafts: evidence for peripheral action of homologous antiserum.

R Morris, Z J Lucas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4106334

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

1.  Immunologic enhancement of rat renal allografts. I. Comparative morphology of acutely rejecting and passively enhanced grafts.

Authors:  A K Abbas; J M Corson; C B Carpenter; E G Galvanek; J P Merrill; G J Dammin
Journal:  Am J Pathol       Date:  1974-05       Impact factor: 4.307

2.  Histocompatibility in organ transplantation.

Authors:  P J Morris
Journal:  Ann R Coll Surg Engl       Date:  1973-12       Impact factor: 1.891

3.  Prolonged survival of renal allografts in outbred rabbits treated with donor specific F(ab')2 alloantibody.

Authors:  D E Sutherland; R J Howard; S Dombrovskis; J S Najarian
Journal:  Ann Surg       Date:  1974-12       Impact factor: 12.969

4.  Immunologic enhancement of rat renal allografts. III. Immunopathologic lesions and rejection in long-surviving passively enhanced grafts.

Authors:  A K Abbas; J M Corson; C B Carpenter; T B Strom; J P Merrill; G J Dammin
Journal:  Am J Pathol       Date:  1975-05       Impact factor: 4.307

5.  Lung injury mediated by antibodies to endothelium. II. Study of the effect of repeated antigen-antibody interactions in rabbits tolerant to heterologous antibody.

Authors:  G Camussi; P R Caldwell; G Andres; J R Brentjens
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

6.  Lung injury mediated by antibodies to endothelium. I. In the rabbit a repeated interaction of heterologous anti-angiotensin-converting enzyme antibodies with alveolar endothelium results in resistance to immune injury through antigenic modulation.

Authors:  L M Barba; P R Caldwell; G H Downie; G Camussi; J R Brentjens; G Andres
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.